U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT07530666) titled 'Study of the Safety and Efficacy of DS010 in Patients With Cancer Cachexia' on April 01.
Brief Summary: A study to evaluate the safety, tolerability, and preliminary efficacy of DS010 in patients with cancer and cachexia
Study Start Date: April 30
Study Type: INTERVENTIONAL
Condition:
Cancer
Cachexia
Intervention:
DRUG: DS010 injection
Once every 3 weeks intravenously injection
DRUG: DS010 injection
Once every 3 weeks intravenously injection
DRUG: DS010 injection
Once every 3 weeks intravenously injection
DRUG: DS010 injection
Once every 3 weeks intravenously injection
DRUG: DS010 injection
Once every 3 weeks intrave...